ExploreWatchlistsPricing
  1. JP-listed companies
  2. Eisai Co., Ltd.
  3. Financials
  4. Gross profit

Eisai Co., Ltd. (4523)

Market cap
¥1.43T
P/E ratio
33.2x
Eisai develops, manufactures and sells prescription drugs and over-the-counter medicines globally across Japan, North America, China, Europe and Asia.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndGross profit (Million JPY)YoY (%)
Mar 31, 2025620,593+5.83%
Mar 31, 2024586,417+3.50%
Mar 31, 2023566,566-2.55%
Mar 31, 2022581,395+19.97%
Mar 31, 2021484,632-6.79%
Mar 31, 2020519,929+13.44%
Mar 31, 2019458,340+97.81%
Mar 31, 2018231,702+26.33%
Mar 31, 2017183,410-14.30%
Mar 31, 2016214,025+3.16%
Mar 31, 2015207,476

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat